10.1007/s00592-010-0195-3 78
Who Should Not Use GLP-1 Medications According to standard clinical guidelines and prescribing information, GLP-1 medications may not be appropriate for individuals who: Have a personal or family history of medullary thyroid carcinoma Have multiple endocrine neoplasia syndrome type 2 Have a history of pancreatitis Have severe gastrointestinal disease (gastroparesis, inflammatory bowel disease) Are pregnant, planning to become pregnant, or breastfeeding Have a history of severe allergic reactions to semaglutide, tirzepatide, or any inactive ingredients This is not a replacement for prescribed medical treatment for any health condition
This is particularly useful if you suspect your thyroid issues are autoimmune-related (Hashimotos), which can significantly impact how you feel even if your TSH is "normal." Gold: The Health Snapshot The Thyroid Premium Gold tier is often our most popular choice for those struggling with fatigue and weight
Triple Threat The initial versions of the drugs, including semaglutide (the generic name for Wegovy, which is produced by Novo Nordisk) targeted one gut hormone: GLP-1
Our goal is happy patients, and we never want to push you into a treatment you do not want
